Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice

Konstantin Stark, Vanessa Philippi, Sven Stockhausen, Johanna Busse, Antonella Antonelli, Meike Miller, Irene Schubert, Parandis Hoseinpour, Sue Chandraratne, Marie-Luise von Brühl, Florian Gaertner, Michael Lorenz, Alessandra Agresti, Raffaele Coletti, Daniel J Antoine, Ralf Heermann, Kirsten Jung, Sven Reese, Iina Laitinen, Markus SchwaigerAxel Walch, Markus Sperandio, Peter P Nawroth, Christoph Reinhardt, Sven Jäckel, Marco E Bianchi, Steffen Massberg

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Deep venous thrombosis (DVT) is one of the most common cardiovascular diseases, but its pathophysiology remains incompletely understood. Although sterile inflammation has recently been shown to boost coagulation during DVT, the underlying molecular mechanisms are not fully resolved, which could potentially identify new anti-inflammatory approaches to prophylaxis and therapy of DVT. Using a mouse model of venous thrombosis induced by flow reduction in the vena cava inferior, we identified blood-derived high-mobility group box 1 protein (HMGB1), a prototypical mediator of sterile inflammation, to be a master regulator of the prothrombotic cascade involving platelets and myeloid leukocytes fostering occlusive DVT formation. Transfer of platelets into Hmgb1-/-chimeras showed that this cell type is the major source of HMGB1, exposing reduced HMGB1 on their surface upon activation thereby enhancing the recruitment of monocytes. Activated leukocytes in turn support oxidation of HMGB1 unleashing its prothrombotic activity and promoting platelet aggregation. This potentiates the amount of HMGB1 and further nurtures the accumulation and activation of monocytes through receptor for advanced glycation end products (RAGE) and Toll-like receptor 2, leading to local delivery of monocyte-derived tissue factor and cytokines. Moreover, disulfide HMGB1 facilitates formation of prothrombotic neutrophil extracellular traps (NETs) mediated by RAGE, exposing additional HMGB1 on their extracellular DNA strands. Eventually, a vicious circle of coagulation and inflammation is set in motion leading to obstructive DVT formation. Therefore, platelet-derived disulfide HMGB1 is a central mediator of the sterile inflammatory process in venous thrombosis and could be an attractive target for an anti-inflammatory approach for DVT prophylaxis.

Original languageEnglish
Pages (from-to)2435-2449
Number of pages15
Issue number20
Early online date17 Nov 2016
Publication statusE-pub ahead of print - 17 Nov 2016

Keywords / Materials (for Non-textual outputs)

  • Animals
  • Blood Platelets
  • Disulfides
  • HMGB1 Protein
  • Inflammation
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myeloid Differentiation Factor 88
  • Receptor for Advanced Glycation End Products
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Venous Thrombosis
  • Journal Article
  • Research Support, Non-U.S. Gov't


Dive into the research topics of 'Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice'. Together they form a unique fingerprint.

Cite this